pd 153035 has been researched along with Angiogenesis, Pathologic in 3 studies
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline: structure given in first source
PD-153035 : A member of the class of quinazolines carrying a 3-bromophenylamino substituent at position 4 and two methoxy substituents at positions 6 and 7.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conconi, MT | 1 |
| Marzaro, G | 1 |
| Urbani, L | 1 |
| Zanusso, I | 1 |
| Di Liddo, R | 1 |
| Castagliuolo, I | 1 |
| Brun, P | 1 |
| Tonus, F | 1 |
| Ferrarese, A | 1 |
| Guiotto, A | 1 |
| Chilin, A | 1 |
| Swanson, CD | 1 |
| Akama-Garren, EH | 1 |
| Stein, EA | 1 |
| Petralia, JD | 1 |
| Ruiz, PJ | 1 |
| Edalati, A | 1 |
| Lindstrom, TM | 1 |
| Robinson, WH | 1 |
| Li, M | 1 |
| Ye, C | 1 |
| Feng, C | 1 |
| Riedel, F | 1 |
| Liu, X | 1 |
| Zeng, Q | 1 |
| Grandis, JR | 1 |
3 other studies available for pd 153035 and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose- | 2013 |
Inhibition of epidermal growth factor receptor tyrosine kinase ameliorates collagen-induced arthritis.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Becaplermin; Cell Division; Cyclooxygenase | 2012 |
Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy.
Topics: Animals; Blotting, Western; Carcinoma, Squamous Cell; Cell Division; Cells, Cultured; Collagen; Down | 2002 |